References
- Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnany and the risk of preterm birth, low birth weight, intrauterine growth restriction. Arch Gen Psychiatry 2010;67:1012–24
- Bánhidy F, Ács N, Puhó E, Czeizel AE. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur J Obstet Gynecol Reprod Biol 2006;124:47–52
- Ács N, Bánhidy F, Horváth- Puhó E, Czeizel AE. Maternal panic disorder and congenital abnormalities: a population-based case-control study. Birth Defetcts Res A Clin Mol Teratol 2006;76:253–61
- Rambelli C, Montagnani MS, Oppo A, et al. Panic disorder as a risk factor for post-partum depression: results from the Perinatal Depression-Research&Screening Unit (PND-ReScU) study. J Affect Disord 2010;122:139–43
- Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004;26:289–95
- Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1–194.e5
- ACOG Practice Bulltein. Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111:1001–20
- Yazıcı O. After Star-D: treatment resistant depression. Arch Neuropsychiatr 2009;46:61–9
- Watanabe N, Omori IM, Nakagawa A, et al. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs 2010;24:35–53
- Gentile S. Drug treatment for mood disorders in pregnancy. Curr Opin Psychiatry 2011;24:34–40
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, D.C: American Psychiatric Press; 1997
- Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, Welfare publication (ADM) 76–338. Rocville, MD: National Intitute of Mental Health; 1976:218–22
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56–62
- Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006;67:1280–4
- Rocha FL, Fuzikawa C, Riera R, Hara C. Combination of antidepressants in the treatment of major depressive disorder. J Clin Psychopharmacol 2012;32:278–81
- Schwarzer V, Heep A, Gumbruch U, Rohde A. Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine. Arch Gynecol Obstet 2008;277:67–69
- Guclu S, Gol M, Dogan E, Saygili U. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 2005;272:298–300